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Abstract
We consider a novel application of quality control charts to brain scans performed
using magnetic resonance imaging (MRI). Although our primary focus is on volume
measures resulting from brain scans, issues related to the MRI scanner are also
considered. The project evaluates a population of healthy control subjects using
control charts to assess the MRIs obtained for the subjects. The results demonstrate
our ability to automatically detect brain volumes that are statistical outliers, and
can provide a potential cost savings of 10% for a moderately sized study. More
importantly, our applied results will increase the sensitivity of tests from comparisons
made between subject populations due to the fact that certain populations of subjects
can be quickly, efficiently, and automatically identified based on outlier analysis.
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1Chapter 1
Computer-Aided Diagnosis
1.1 Computer’s Role in Disease Detection
Computer-aided diagnosis of neuroimaging data is attracting an increasing amount
of interest, funding, and research. The use of control charts with morphological mea-
surements is a novel application in the neuroimaging field. Journals in the medical
field are dedicating a portion of their space to statistics and quality in medicine.
These articles are intended to promote better and less costly health-care delivery,
and detecting disease more efficiently with fewer errors contributes to that goal. Us-
ing control charts with brain morphometrics is an as yet untouched field of research,
but as this thesis will demonstrate, it is one which may be replete with opportunity
for sampled populations as well as individuals. A sampled population can be more
specifically defined to require both a diagnosed mental illness and the structural
changes that are expected.
For schizophrenia, this would include criteria from the Diagnostic and Statistical
Manual of Mental Disorders (DSM IV), the researcher’s own tests, and expected
morphological changes such as enlarged ventricles.1 They normally increase in size
with age, but are often seen to be enlarged in schizophrenic subjects. Figure 1.1
1The ventricles are located centrally in the brain and hold the cerebral spinal fluid.
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gives more details about how the brain is labeled. With quantitative brain imaging,
the minimum enlargement of the ventricles can be specified. Using control charts
can help determine if the recruited population is meeting the criteria specified in the
study design. Taking a series of scans while a patient is being treated can help to
determine drug efficacy. If it is known that a mental illness affects a portion of the
brain and that effect can be measured, then sampling over time can help to inform
the researcher on whether the drug is working to counter the physical manifestations
of the mental illness. With brain imaging and control charting, the effect would have
to be neuromorphometric, which refers to measures performed on the anatomy of
the brain.
Using a computer to diagnose patients has been of interest since the 1960s. An
overzealous belief in the functionality of the 1960s computer coupled with the reality
of then current computational abilities has made it so that the fervor which grows
from reading about the possibilities dies with the realized difficulty of getting a ma-
chine to perform the functions of a doctor. Money does get seeded into the related
field of computer-aided diagnostics. The current explosion of medical data can over-
whelm medical personnel, but with computers the diagnostician can be facilitated by
the algorithms developed for producing plausible differential diagnoses. The medical
teams efforts can be used to treat possible scenarios rather than eliminate unlikely
diagnoses. Computers role in medicine can facilitate diagnosticians, perform quality
assurance, aide in training future physicians, and ultimately improve patient care
Summers (2003).
For Magnetic Resonance Imaging (MRI), computers have been essential. Al-
though the first MRI images had limited resolution, only a computer made the
immense calculations possible. The images produced from the first MRI machines
demonstrated the possibility of being able to look at the internal physiology without
the use of radiation, but the images were also poor and unable to delineate the brain’s
anatomy. Paul C Lauterbur helped to develop the technology for two-dimensional
imaging and Peter Mansfield helped to develop the mathematics to increase the speed
by which an image could be acquired. Both received a Nobel prize in Physiology or
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Medicine in 2003. The current state of MRI technology allows viewing the topology
produced from a scan (Doi (2007)).
MRI imaging consists of stacking the two-dimensional images in order to produce
the three-dimensional image. The thinner each two-dimensional image is, the greater
the accuracy of the thee-dimensional image. Scanner sensitivity is increasing rapidly
and eventually radiologists will not be able to scroll through the collection of two-
dimensional images.
One method for getting around this problem of data explosion is to down sample
the data: have the researcher look at every other planar image or every third, but
this would unnecessarily decrease the amount of data available to the researcher.
Computers and mathematical algorithms are an ideal alternative to down sampling
because they are not constrained by the same factors as humans. As the algorithm’s
sensitivity to abnormalities in the scan continues to increase, the computer can direct
the radiologist’s attention to problem areas. This diagnostic assistance has already
been in place for two decades, albeit only in mammograms.
Mammography has been using Computer-Aided Diagnostics (CAD) for years with
great success (Kessler (2006)). The breast is a more homogenous tissue than the
brain. We have good theories about the brain’s function, but we are still baffled by
it’s plasticity.2 We do not always know what causes brain cells to switch and become
diseased, but sometimes the diseased tissue is nearly indistinguishable from normal
healthy tissue. With lesions, researchers only know of the diseased tissue because
of its location relative to other structures and its placement within a structure.
Brain lesions can resemble other tissue types and can be difficult for a computer to
distinguish from healthy tissue.
Lesions do not maintain their volumes over time; they can shrink and grow. This
is also true of the brain and the structures of the brain. Over time, the relative
proportion of gray matter and white matter changes (Tofts (2003)), but it does not
2Plasticity is the ability for one section of the brain to take over the functions of another
ailing section.
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occur too quickly in healthy brains until after age seventy (Scahill et al. (2003)).
Knowing that brain structure volumes fluctuate over time lends itself to the use of
quality control charts. Control charts are intended to use a time component in order
to detect observations that are trending towards being out of control. A control chart
should detect that the measurement of a product is trending to an out of control
value before it actually does.
1.2 Software Used in MRI Studies
Dissecting the brain into areas of functionality and structure is integral to the explo-
ration of human anatomy classes. Prior to imaging techniques, it was a destructive
process - usually performed postmortem for humans, but sometimes done with live
animals. Researchers also studied people that had known trauma to specific areas
of the brain. Unfortunately, studying people that previously had brain trauma is
not a well controlled experiment and is not repeatable. This creates an inference
problem. X-rays and Computer Tomography (CT) scanners both give images of the
brain, but they also irradiate the patient, which is a health hazard. As the MRI
scanner became a common diagnostic tool, computers and programs were developed
that could efficiently handle the administration, collection, and analysis of the data.
MRI scanners do not suffer from causing known harm to a person, can be repeated,
and are often used in controlled designed experiments.
Figure 1.1 is a graphic of a brain that has many of it’s structural components
labeled. Labeling the structural components of a brain is also known as segmenting.
“Segmenting” or “Parsing” a brain was done by hand by a radiologist when MRI
technology was first introduced. Eventually, technicians were trained to perform
the task, but modern day scanners can produce a structural image in less than
15 minutes. Technicians could not manage that workload, so the computer and
relevant software were introduced to automate the process. In fact, the low number
of segmentation errors is leading to a general acceptance outside of research of the
functionality of these software packages. We have most extensively worked with the
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Figure 1.1: Segmented Brain
structural imaging packages Brains2 (Magnotta et al. (2002)) and Freesurfer (Fischl
et al. (2004)), but many other packages exist. Freesurfer was selected because of it’s
robustness, programmability for automation, and cortical thickness measurements.
A Freesurfer segmentation is shown in Figure 1.2. It does not look exactly like
Figure 1.1 due to stripping away of the pial3 surface. Each shaded area represents a
different segmented area of the brain.
The software automatically generates a complete and detailed labeling of the
entire cortex using prior information, cortical geometry, and a space-varying classi-
fication procedure (cf. Fischl et al. (2004)). Fischl et al. (2004) provided the details
for section 1.2. Automating the software to label cortical gyri and sulci (folding
patterns in the brain) is performed using the framework of Bayesian parameter es-
timation theory. P refers to a parcellation and S refers to a surface. Using Bayes’
Theorem, the probability of a parcellation given an observed surface is related to the
probability of a surface given a parcellation together with the prior probability of
3Pial refers to the outer surface of the brain
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Figure 1.2: Freesurfer Rendering of a Brain
the parcellation, or:
p(P | S) ∝ p(S | P )p(P )(1.1)
The advantage of a Bayesian approach is the incorporation of prior information
through the p(P) term. An atlas space is a set of prior information that gives
probabilities for segmentations occurring in a particular area of the brain, i.e. the
frontal lobe has no chance of being classified as if it were in the back of the skull.
The problem is more tractable when an atlas space is incorporated into the model,
thus allowing both the priors on P and the probability of observing the surface given
the classification to depend on the position in the cortical surface. In order for this
process to work across subjects, a function f(r) must be built which uses the raw
image coordinate and maps it to the corresponding coordinate in the atlas. Subjects
are therefore mapped to one atlas which allows comparability across subjects. The
joint probability of the mapping function f and the parcellation P, are given by:
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p(P, f | S) ∝ p(S | P, f)p(P | f)p(f)(1.2)
The first term contains information on the class statistics which vary as a function
of location, the second term expresses prior information regarding spatial structure
of the parcellated labels, and the third term constrains the space of allowable atlas
functions. The Freesurfer team used both a manual parcellation of subject brains
along with a probabilistic brain created from the subjects to build the atlas. If
a single subject had been used as the atlas, then the idiosyncrasies of the subject
would appear in the atlas. Using an entirely probabilistic mapping may cause cer-
tain anatomical information to be lost. The team therefore went with both manually
segmented brains and a statistically processed brain for obtaining the prior proba-
bilities for a structure’s location. The atlas that was generated provides two forms of
prior information: the first gives the probability of a parcellation label occuring at a
location in the atlas which is provided by f and the atlas; the second is an indicator
for possible locations of parcellation labels. The second bit of information eliminates
the possibility of extremely erroneous labels such as ‘the right thalamus is on the left
side of the brain.’
Given f, the atlas function, and N manually parcellated subjects, an estimate of
the occurrence of c, the prior probability of parcellation when independent of other
locations is:(
P (r) = c
)
=
(
number of times class c occurred at locationf(r)
number of times that map to r in the training set
)
(1.3)
This equation finds the agreement between the manual parcellation of the brain
with the statistical priors used to parcellate the brain. Two quantities representing
the observed surface S are encoded as a vector G(r) at each point in the surface S.
(r refers to the spherical atlas coordinates, while f(r) refers to the subject’s spherical
coordinates.) The two vector values are average convexity and mean curvature,
but other quantities such as T1 and T2, Gaussian curvature, or cortical thickness
can be incorporated. The likelihood of observing the surface geometry G given the
parcellation label P(r) is a Gaussian model with parameters:
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µc(r) =
1
M
M∑
i=1
Gi[f(r)](1.4)
that give the likelihood of observing the surface geometry G given the parcellation
label P(r). A set of M surfaces occurs for label c at location f(r) in the manually
labeled surface models Si. The Gi are the geometric parameters extracted from the
set of M surfaces. Class c at location r has covariance matrix:
Σc(r) =
1
M − 1
M∑
i=1
[
Gi[f(r)]− µc(r)
][
Gi[f(r)]− µc(r)
]T
(1.5)
Geometric information across classes needs to be averaged because the informa-
tion about the surface geometry is maintained separately for each parcellation label
at every atlas location. An estimate of pairwise probabilities that two parcellation
labels c1 and c2 occur when the labels are at locations ri and r, respectively, with
ri ∈ N(r). is expressed mathematically,
p[P (r) = c1 | P (r) = c2, ri] =
(1.6)
# of times c2 occured at location ri when c1 occurred at r
# of times class c1 occurred at location r
This information is stored separately for each atlas location. The probabilities
are stored separately for each pair of classes and for each neighborhood location r,
but due to the sparseness of the matrix, the computations remain tractable.
Freesurfer computes the maximum a posteriori (MAP) estimate of the parcella-
tion P given the input surface geometry G and the nonlinear spherical transform f.
Bayes’ Thereom gives:
p(P | G, f) ∝ p(G | P, f)p(P )(1.7)
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which can be re-written if the noise at each vertex is assumed to be independent
from other vertices in the model as:
p(G | P, f) =
∏
r∈S
p
[
G[f(r)] | P (r)
]
(1.8)
The geometric properties of each class at each atlas location are distributed as a
Gaussian with mean vector µc(r) and covariance matrix Σc(r). The probability of
G[f(r)] is expressed as:
p
[
G[f(r)] | P (r) = c
]
=
(1.9)
1
|Σc(r)|1/2
√
2pi
exp
[
−.5
(
G[f(r)]− µc(r)
)]T
Σcr
−1
[
G[f(r)]− µc(r)
]
Freesurfer assumes the prior probability of each parcellation P by assuming the
spatial distribution of labels are well approximated by an anisotropic non-stationary
Markov random field. Non-stationarity allows the prior information about the re-
lationship between labels to be expressed as a function of location while anisotropy
allows for the expression of direction. In essence, the location and direction are
important and not interchangeable. The Markov assumption is written as:
p[P (r) | P (S − r)] = p
[
P (r) | P (r1), P (r2), . . . , P (rk)
]
, where ri ∈ N(r)(1.10)
Equation 1.10 means that the prior probability of a label at a vertex r is influenced
only by it’s neighbors. The log-likelihood function gives:
p(P ) =
∏
r∈S
p[P (r) | P (r1), P (r2), . . . , P (rk)], where ri ∈ N(r)(1.11)
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and Bayes’ Thereom transforms the equation into:
p(P ) ∝
∏
r∈S
p[P (r1), P (r2), . . . , P (rk)) | P (r)], where ri ∈ N(r)(1.12)
In order to make this a tractable problem, the first order conditional dependence
is used. That is, only the local neighbors are used and the equation is rewritten as:
p
[
P (r) | P (r1), P (r2), . . . , P (rk)
]
=
∏
r∈N(r)
p[P (r) | P (ri), ri](1.13)
The maintenance of ri emphasizes that the probability densities are maintained
separately for each neighbor position in N(r). The full parcellation of the brain’s
prior probabilities can be expressed as:
p(P ) ∝
∏
r∈S
p[P (r)]
K∏
i=1
p[P (r) | P (ri), ri](1.14)
This technology enables researchers to automatically parcellate MRI scans so
that limited research resources can be spent elsewhere. Some errors do occur in the
processing and minor post processing is needed, but the advantages of a nearly perfect
inter rater agreement, scalability, cost, and efficiency far outweigh the disadvantages.
1.3 Control Charts and Quality Assurance Soft-
ware
Once the data were measured by Freesurfer it was placed in text files. The text files
were aggregated using custom PERL scripts. The SAS language was used to create
control charts. PROC SHEWHART was used for the three different control charts
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developed for these data: a whole volume chart, a percent of total volume chart, and
a regression control chart. More details of what each of these charts represent is given
in Chapter 5.2, but briefly: a Whole Volume Chart is the raw measure of the brain
structures, a Percent of Total Volume Chart is the proportional amount of volume
that a structure in the brain occupies relative to the entire brain volume, and a Re-
gression Control Chart uses the residuals after regressing the dependent structure on
the covariates. There were 29 structures which were measured and validated, but the
scale of their measurements are not all the same. Some structure’s measurements
differ by 1, 2, 3 or more scales of magnitude. PROC UNIVARIATE was used to
find out the number of significant digits present in the mean of the structure’s mea-
sure for scaling the axes. This was encoded in a macro variable, providing PROC
SHEWHART the number of decimal places to use in chart construction. Macros
eliminated much of the tedium of data preparation. The functionality of the macros
that were created were: build and name the control charts with appropriately scaled
metrics, regress structural variables on a single structure, and regress a structure with
behavioral data. These are fairly powerful programs because they can be re-used,
but added into this mix is some less-portable code which took the resulting data sets
and generated tables of outliers. The development of this code took several months
of work and even code execution can run up to 2 hours because of the number of
charts and regressions performed. It has been made as efficient as possible and for a
single Whole Volume Chart takes less than a second to run.
Scanning several subjects several times over multiple years is the ideal test of con-
trol chart usefulness in detecting changes in morphology. However, this is also the
most impractical because the inevitable changes in brain composition can take years
to occur in healthy subjects. MRI scanning is extremely costly (discussed in Chap-
ter 5.3) and so are longitudinal studies. Scanners are very profitable multi-million
dollar pieces of equipment and are therefore upgraded as frequently as possible. In
general, study attrition rates depend on the study complexity, subject motivation,
time commitment, and many other factors. All attrition rate factors are tested with
MRI scans and so a large starting sample is essential. The cost and the time com-
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ponent are not only the key pieces to a study on using control charts to assess brain
morphology, they are also the barriers.
Our data set has seventy-one healthy subjects scanned once in the same year
on the same scanner. This removes the inter-scanner differences and most of the
variability from changes in a scanner. The study design also eliminates the ability to
show that a single subject can be used on a control chart to detect when their brain
scans become abnormal. The study demonstrates the feasibility of using control
charts with morphometrics and encourages the exploration of other methods for
detection of abnormal scans.
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Chapter 2
Quality Control Charts
2.1 Introduction
Dr. Walter A. Shewhart (1891-1967) published a memo in the 1920’s that lead
eventually to his publication of the first book on statistical quality control (Shewhart
(1931)). His ideas were revolutionary and have since proven to be instrumental in the
technological developments of this last century. Statistical quality control ideas are
used in manufacturing, medicine, computers, programming, and many other fields.
He also influenced Dr. W. Edwards Deming (1900-1993), a man instrumental in
process improvement of manufactured items during World War II and in post-war
Japan.
There are a number of control charts used in industry and they are seeping into
medical practices as well. Researchers are finding methods to monitor the quality of
healthcare delivery. Recently, Quality Engineering (Volume 20, Issue 4, 2008) did a
special issue dedicated to quality control and healthcare. The area of quality control
charts in medicine has a set of challenges not found in more traditional industrial
technologies. In the medical field data are finicky and sensitive to violations of
assumptions. Astronomically increasing costs of medicine are focusing funding on
both the problems and solutions that may be the drivers of costs. We review a few
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Figure 2.1: Sample Control Chart
of the more commonly used control charts, including: X¯-charts, R-charts, S-charts,
attributes charts, multivariate charts, and Individuals charts. Montgomery (2005)
and Ryan and Ryan (2000) both offer excellent introductory quality control chart
textbooks.
2.2 Quality Control Charts
A sample control chart is given in Figure 2.1. The key feature of a control chart is
the time component which allows for detecting a subtle trend in a process. Figure
2.1 has had drift introduced at point 16, but depending on the rules used by the
engineer, the drift may not be caught until point 25.1 Sudden or dramatic changes
in the process can be caught just as easily with an outlier analysis, but by the time
a production process is that far out of range, several items will have likely been
produced that were outside specifications.
18 samples in a row above center line
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The ideal way to catch out of control points is to test everything frequently,
but this is not usually economical. Over testing displaces the equity maintained
between production costs and profitability. The manner in which a process can be
tested determines how frequently it will be tested. Destructive, costly, and slow
production rates all require infrequent quality testing. Automatic, inexpensive, and
fast production rates are areas where frequent quality testing can be performed. The
control charts used in each of these situations depends on what methods are available
to the engineers.
An X¯-chart averages the measurements made on a small sample (subgroup) of
manufactured product and assigns that value to the lot that was produced. It is
assumed the small sample is representative of the lot. Over time each of these
samples are plotted and a lot by lot time series is produced. The time series would
look similar to Figure 2.1. X¯-charts indicate if the mean is in control, but the
variability is not monitored and could be changing.
If the sample sizes are between 2 and 10 units, an R-chart is used in conjunction
with the X¯-chart. R-charts use the range of values in order to estimate the variability
in the data. The range of a sample from a normal distribution is related to the
standard deviation by W = R/σ where W depends on the sample size n. The mean
of W is d2, a quantity that can be found in a text such as Montgomery (2005), which
gives an estimate σˆ = R/d2.
If the sample size is greater than 10, R becomes a less accurate measure of the
standard deviation. An S chart is used instead where the standard deviation is
computed from the sample. Historically, prior to the availability of computers, R-
charts were popular because of their ease of calculation. S-charts are always a better
estimate of variability.
An attribute chart can be useful for MRI data. Attribute charts find the propor-
tion of acceptable product produced in each lot and therefore a binomial distribution
can model the observations. They are often used when items are assembled and pro-
duced or when it is difficult or too costly to develop an objective metric for the
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system. For example, a company manufacturing dolls could set up control charts for
whether the dolls had two eyes, two hands, two feet, etc. However, any one of those
defects means the doll needs to be scrapped or reworked and so using an attributes
chart makes more sense than modeling every component with it’s own control chart.
If the probability of an event is too small (or too large), the binomial distribution’s
control limits start misbehaving and taking on values outside the range possible for
the binomial. Essentially, this means if we are using an attributes chart and the
defect rate is low, the chart is not useful because it can not detect shifts or trends
that may lead to a process being out of control. An attribute chart does not con-
sider what components failed and lead to rejection. If we wanted to know how many
defects occurred in a product, we might consider a Poisson distribution, which is a
good approximation for phenomena that occur on a per unit basis. A right-skewed
Poisson distribution corresponds to a low defect rate.
A multivariate chart looks at several attributes at the same time and considers
those attributes as a whole to determine if a product or batch is to be rejected. If
we constructed a box, a multivariate chart could be used to ascertain if the height,
width, and depth of the box were within pre-specified limits. All three attributes
could be within specifications, but the sum total of the error of the three could add
up so the box is rejected. A multivariate chart is able to detect the case in which
the sum of the parts produces a defective product, but the individual parts pass
inspection.
For these data, Individuals Charts will be used. Individuals charts lend them-
selves to situations in which every product can be sampled inexpensively and non-
destructively. Weight measurements performed daily is an example data set that
would use an Individuals Chart. One sample weight taken at the same time daily
would be a useful metric to determine weight stability over time. It is an inexpen-
sive and quick method for assessing weight control. Relative to the cost of an MRI
study and all of the processing that will already be put into assessing the scans, the
creation of control charts on morphological data is also inexpensive. The Individuals
Chart will be used on the raw data, a normalization of the data, and the residuals
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Figure 2.2: Extreme case of Motion in an MRI scan
after regressing the data on covariates.
We will assess healthy normal subjects 18-25 years of age which have had their
structural MRI brain scans regionally segmented and measured by the Freesurfer
software. Control charts allow for a quantitative evaluation of subject scans. Assess-
ing brains with control charts has to-date not been published in the quality control
or radiology literature. Individuals Charts were used for the example analysis in
section 2.1, but other charts can be used under different sampling schemes.
The MRI scanner is our measurement tool and is expected to be in control because
of quality assurance performed by the MRI technicians. The production cycle of a
brain is somewhat obvious: conception, pregnancy, birth, and life up to the point of
scanning. Events that may affect brain development include: trauma, disease, mental
illness, alcohol and drug use, or physical abuse. A nurture argument may also include
events like happiness, encouragement, or verbal abuse as having a significant affect on
the production process (Johnson et al. (2002)) Knowledge of events such as trauma,
disease, or mental illness can help the person examining quality control charts on
brain images assign cause to out-of-control signals and can also be used in regression
control charts. Unlike in industry, the subject can not be “scrapped” or re-worked,
but the subject can be excluded from future analyses based on their morphometric
profile. The rigor requisite for classifying a subject based solely on morphometrics
is not present and social factors should not be ignored (Johnson et al. (2002)).
The other measurement the control charts will be considering is the quality of the
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scan. Most software packages will fail if a brain scan has too much motion artifact.
If there is little motion artifact, the segmentation can move forward, but erroneous
measures are likely to occur. The control charts should be able to flag those errors.
2.3 Individuals Charts
The paradigm being used is that each brain is identically and independently sampled.
The subjects and their brains were randomly selected. Each brain has undergone
a “manufacturing process” about which we know little and are unable to control.
The only option available to the researcher is to reject a person from the study.
Rejecting a data point without assignable cause is acceptable, but has no analytical
justification (Montgomery (2005)).
The Individuals Chart is considered to be a Shewhart Chart because it falls under
the paradigm developed by Shewhart. A control chart can accomplish three things
(Duncan (1965)):
1. It defines the goal or standard for a process that management might strive to
attain.
2. It is used as an instrument of attaining that goal.
3. It serves as a means of judging whether the goal has been reached.
Our purpose is to define a goal or standard. The data we have are being used to
estimate the control limits. This means that the control charts are in Phase I. Phase
II would mean that prior limits have already been established and are set for a future
data set (Montgomery (2005)).
Montgomery (2005) gives five reasons for using an Individuals control chart:
1. Automated inspection and measurement technology is used, and every unit
manufactured is analyzed so there is no basis for rational subgrouping.
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2. The production rate is very slow, and it is inconvenient to allow sample sizes
of n > 1 to accumulate before analysis
3. Repeat measurements on the process differ only because of laboratory or anal-
ysis error
4. Multiple measurements are taken on the same unit of product.
5. Measurements on some parameter will differ very little and produce a standard
deviation that is too small to be significant.
Reasons 1, 2, and 3 apply to quality control charts for brain measures.
  
Birth MRI
Production time
MRI
Production time
More 
Scans
Figure 2.3: Diagram of production time between MRI scans
The segmentation of the brain is automated as was noted in chapter 1.2. Using
the Freesurfer software it can take up to 34 hours to segment a brain and a few more
minutes to perform measurements. The 34 hours is analogous to weighing an object
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on a scale; it simply takes a long time to “weigh” an MRI scan. Production time
would be the time it takes to scan the brain again. Steen et al. (2007) re-scanned his
subjects after 12 weeks which gives a production rate of once every 12 weeks. The
authors were looking for changes in morphology after a short period of time which
they did not find in subjects that had not suffered a serious event affecting their
brains (such as stroke, vehicular accident, or other catastrophe). Since Steen et al.
(2007) did not see appreciable changes in morphology after 12 weeks, it is unlikely
any would be seen after a few minutes. The few minutes corresponds to the time
it would take to rescan a subject. The algorithms used in the Freesurfer software
are somewhat robust and the process will differ very little. Freesurfer will produce
a segmented image that is then measured by region.
Our primary interest is in three preliminary research questions.
1. Whether or not a subject is structurally within normal limits.
2. The quality of structural scans.
3. The image analysis pipeline’s performance in correct brain parcellation.
Although the three questions are inter-related, each is considered separately.
For this study, the subject was entered into the study based on the profile provided
by a battery of psychological tests. In other studies, a researcher will try to use a
set of healthy controls for comparison against mentally ill subjects. The number
of psychological tests and clinical interviews necessary to rule out all diseases and
declare a subject as a healthy normal control is prohibitive; therefore a subset of
tests is used. Declaring someone healthy when they are not is a type II error. The
control chart helps to mitigate the effects of type II errors by determining whether
the subject’s morphology based on the MRI is also considered to be within normal
limits.
Quantitatively valid scans are currently not a clinical requirement (Tofts (2003)).
However, in the future, comparability of scans may be essential which would require
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quantitative validity (Tofts (2003)). Our scans meet that requirement and allow us
to objectively state whether a region is structurally within normal limits. That is,
the subject is within the control limits set by the study data. This is Phase I because
we do not use reliable a priori limits.
Figure 2.4: The healthy brain is on the left and the schizophrenic brain is on the
right. Courtesy of kevinturnquist.org/images/housing21.jpg
Statistically significant structural volume differences between subject populations
exist, for example between a non-schizophrenic subject’s and a schizophrenic sub-
ject’s regional brain volumes.
Differences are found between brain structures of subjects with disease versus
those considered normal (Miller et al. (2002)).
Although there are a number of research studies that involve “brain”, “volume”,
and “magnetic resonance” in the medical literature (Worth et al. (2001); Tofts
(2003)), currently none in statistical quality assurance literature have addressed
this area. In recent years, quality control techniques are finding applications in
the healthcare industry (cf. Woodall (2006); Manos et al. (2006); Benneyan et al.
(2003)). Studies are able to discern volume differences between healthy controls and
subjects, but their assessment of health status is based on psychometrics rather than
a fusion of psychometrics and morphometrics (cf. Castellanos et al. (2001); Grachev
et al. (1998); Plessen et al. (2006); Strakowski et al. (1999); Szeszko et al. (1999)).
The second question considers the quality of the structural scans. Jovicich et al.
(2006) informs us that many different artifacts can affect image quality such as oper-
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ator skill level, subject motion, scanner inhomogeneity, magnetic field nonuniformity,
and so on. For example, when placing a subject in the scanner, the static magnetic
field is adjusted and becomes inhomogeneous. Several saturation scans are performed
to reduce the inhomogeneity; however, the effects of air pockets (e.g. sinuses), cannot
be eliminated in full.
The precision of a subject’s volume measures can change with cardiac and breath-
ing patterns (Tofts (2003)). Motion artifacts can cause severe distortions, but as
scanners improve and better head restraint methods are used, the motion artifact
becomes less of an issue. We recommend that quality assurance (QA) procedures
immediately follow a structural scan to minimize the loss of collected data due to
poor image quality, thus allowing for a repeat scan.
Mitigating the rejection of data due to bad scans will increase the potential num-
ber of desirable subjects in a study and decrease variability within subject type. If
QA procedures are implemented, we would know (1) whether the subject is struc-
turally within normal limits, i.e. should the subject keep the same classification as
assigned upon entering the study, and (2) whether the scan is poor. The results of
the quantitative analysis would not change a subject from the status “healthy nor-
mal control” to being in the comparison group based on brain volumes. The subject
may be removed from later analyses due to structural measures that are outside of
normal limits. If the scan is poor, the registration of images becomes more tedious,
region of interest analyses cannot be performed, or the data may need to be deleted
from the analysis.
The third question concerns the performance of software on the images. Note it
is possible the software is unable to process certain brains; a scenario which would
alert the technician to a bad scan. An example scan which would be impossible to
process due to the extreme motion artifact was given in Figure 2.2. This error, when
caught during a scan, makes the final data cleaner and more accessible.
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Chapter 3
Magnetic Resonance Imaging and
Quality
In the information technology age, statistics and computer science are making head-
way in reducing and summarizing the vast amounts of data procured from medical
imaging modalities for medical personnel to digest. Structural MRI (sMR) data is a
large interdisciplinary medical data set that benefits from statistical summarization,
but has yet to be quality assured with control charts. Incidental findings, such as a
neoplasm, have been found in asymptomatic volunteers (cf. Katzman et al. (1999);
Vernooij et al. (2007)). A person can be asymptomatic for a mental illness, but the
physiologically correlated signs of mental illness might be present. Our method helps
flag an abnormal scan quickly so that appropriate medical personnel can be alerted.
We hope for this to be a first step towards automation and routine screenings in
clinical MRI such as already occurs in breast cancer screening (Garvican and Field
(2001)).
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3.1 Physics of Magnetic Resonance Imaging
3.1.1 Introduction
Magnetic resonance imaging (MRI) for the human body is a recent development
in medicine which has overcome many of the pitfalls of computed tomography and
x-ray scans. Magnetic resonance gives well-contrasted images of soft tissue, which
is something neither X-rays nor CT scans do without the use of contrast agents.
MRI does not need radioactive substances in order to produce a structural image
delineating tissue types because differing tissue types have their own characteristic
resonance. This makes it ideal for use in at risk populations such as pregnant women.
The aim of this section is to introduce a brief history of the development of MRI.
3.1.2 Magnetic Resonance Imaging Physics
The history of developing MRI technology is pulled mostly from Mattson and Simon
(1996) while the physics of MRI technology is pulled from Hashemi et al. (1997) and
Tofts (2003). The scientific foundation necessary for brain imaging began at the turn
of the century with Max Planck proposing quantized energy packets for electromag-
netic radiation. America was slow to come to terms with quantum mechanics, but
with several European physicists immigrating to the U.S., academic research in the
“new science” blossomed. World War II provided the necessary impetus for America
to commit extensive resources into exploring the atomic level of matter from which
would come an atomic bomb, the lesser known, but now ubiquitous, science of radar
technology, and the Diagnostic and Statistical Manual of Mental Disorders (DSM).
All three technologies have a role in this thesis. Radar came to the US from Britain
and at the time, the researchers were using a 10 cm wavelength. Developing the tech-
nology to a 5 cm and 2.5 cm wavelength improved the ability of the radar to detect
aircraft. The 1.25 cm radar was an abysmal failure, especially on humid or cloudy
days. Water absorbs energy around 1.33 cm which was close enough to absorb much
of the signal. The reasons behind the loss of signal presented another opportunity
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for research after the war.
MRI works with the magnetism of protons. Spinning charged particles create
electromagnetic fields causing the nucleus to act like a bar magnet. Placing a bar
magnet into an electro-magnetic field will orient the magnet, but at the atomic level,
the field must be maintained or the atoms will re-orient to their preferred space.
The randomization of the atoms after the magnetic field has been turned off was
explained by equations developed by Dr. Felix Bloch. Later he would publish the
theory behind solid state nuclear magnetic resonance, thereby earning a Nobel Prize
in physics in 1952. Edward Purcell and his team initially discovered solid-state
resonance for which Purcell also received a share of the 1952 Nobel Prize in physics.
MRI scans predominantly use the hydrogen nucleus, though other elements with
an odd number of protons can be used. Hydrogen is particularly useful in that it
exists in only two states, known as spin (S), and is very abundant in the body. The
spin of a proton relates to the number of energy states a proton can be in.
Energy states = 2*S+1
Hydrogen’s proton has a spin of 1
2
and therefore has two energy states, one energy
state being higher than the other.
When spinning, unpaired protons are placed in a magnetic field, some will line
up parallel to the field and some antiparallel. Slightly more, a million to a million
minus one, will be in the lower energy state of being parallel to the field.
The sheer number of protons in the body enables such a small difference to be
very significant. The rate at which the protons align themselves follows a growth
curve similar to Figure 3.2.
All electromagnetic waves travel at c = 2.99792458 ∗ 108 meters/second and are
composed of an electric wave and a magnetic wave. Both waves are sinusoidal, out
of phase by 90 degrees, and propagate each other. The magnetic field is what is used
in magnetic resonance while the electric field produces heat, an unwanted side effect.
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Figure 3.1: a) Protons, the circles, are arranged randomly with no external magnetic
field applied b) With the external field (B0) applied, the protons align themselves
with or against the external field
In order to perturb a proton, energy must be added to the system, and, in order
to be absorbed and induce a flip, it must be added at the Larmor frequency which is
in the range of the radio frequencies1 and is the rate at which protons are precessing
1Radio frequencies occur between 3-100 MHz (megahertz).
Figure 3.2: The growth curve of the number of molecules aligning with the external
magnetic field over time
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Source Frequency
AM radio .54-1.6 MHz
TV 64 MHz
FM radio 88.8-108.8 MHz
MRI pulse (RF) 2-100 MHz
Table 3.1: Frequencies of use for common devices
about the main magnetic field. Table 3.1.2 below gives the various radio frequencies
we use everyday.
The magnetization is described by M = 1 − e− tT . For tissue, the rate of net
magnetization is directly proportional to the strength of the external field. Note
that the above equation in no way accounts for tissue type. Tissue type must affect
the rate of magnetization, otherwise brain scans would look uniform with no contrast
between structures.
The reason that field strength affects the T1 relaxation is believed to be due
to the particulates in the tissue. An accepted but unproven explanation is that
particulates modify sub-atomic forces. Therefore it is believed that the particulates
affect the relaxation because they are not made up of protons that are as mobile.
The density of mobile protons within the tissue affects net magnetization and so the
above equation should be M = N(H)(1− e− tT1 ), where N(H) represents the density
of mobile protons.
To induce a signal from the tissue, the scanner must input another weaker radio
frequency pulse at an angle to the main magnetic field. This new magnetic pulse
must also be at the Larmor frequency for the energy to be efficiently absorbed. A
90◦ pulse will cause the protons to flip into the transverse plain, creating a transverse
magnetization. The pulse will also cause some of the protons to absorb energy and
boost themselves into the higher energy state causing a decrease in net magnetization.
As the magnetization decays, a signal (energy) is released from the system and is
detected by coils within the scanner.
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The rate at which the protons begin realigning themselves after the weak radio
frequency pulse is turned off, is determined by the T1 constant. The equation is
Mz(t) = M0(1 − e−
t
T1 ). T2 is the decay of the signal in the transverse plane. T2*
is used instead to account for external field inhomogeneities. The overall signal
intensity that a receiver coil detects follows S = M0(1− e−
TR
T1 )(e
− TR
T2∗ )
Scanners are unable to measure the signal immediately after the radio frequency
pulse has been added to the system. The gradient coils, also known as receivers, wait
a small interval of time before they acquire the signal. This is the Echo Time or TE.
In order to acquire a three-dimensional image, a radio frequency pulse must be
repeated for different planes of the brain. This repetition is known as a TR (repetition
time). Each repetition flips the magnetization vector back into the transverse plane.
As the proton recovers, it will give off a signal. The signal does not have dimension.
The signal received is made up of the T1 and the T2 signals. As the TR increases,
the weighting due to the T1 decreases. As the TE decreases, the weighting due to
the T2 decreases.
3.1.3 Imaging and Contrast
T1 and T2 images emphasize tissues differently and each is used to detect different
things. The cerebral spinal fluid is very dark in a T2 image while it is bright in a T1
image. This is expected because the images are inversely proportional to each other.
The T2 image is affected by external magnetic field inhomogeneities and by spin-
spin interaction. Water is not usually isolated in a human and therefore spin-spin2
interactions cause the T2 relaxation time to be long. Solids are compact and the
dephasing caused by spin-spin interactions is prevalent. Fat has a relaxation time
between that of solids and water.
The T2 properties are related to the efficiency of the system to absorb or give
2This is the interaction between hydrogen protons
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Figure 3.3: Relative relaxation times for CSF, White matter, and Grey Matter
off energy to the surroundings. If the translation, rotation, or vibrations are at the
Larmor frequency, the system absorbs or releases energy at the most efficient rate.
Figure 4.1 shows the signal intensity of Cerebral Spinal Fluid (CSF), White Matter,
and Gray Matter changes with respect to time.
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Chapter 4
Application
4.1 Introduction
Neuropsychology examines the relationship between the structure of the brain and
psychological manifestations. It is a field that has rapidly expanded over the last
three decades, and now is so replete with research that no one could possibly hope
to stay abreast of all current practices. Most of our background information was
contributed by Lezak (1995). Similar to the science for MRI and the statistics of
quality control, neuropsychology found it’s beginnings in the early 20th century
with a rapid increase in research during the 1970’s. The mental and emotional
manifestations of physical brain damage are not well understood, except to say there
are generalizations which neuropsychological literature reports. Currently research
is being conducted in developing tools that would allow the MRI scanner to be
used as a diagnostic tool for mental health. This is one reason why comparisons
are performed between healthy normal controls and subjects with mental health
problems. In using control charts to reject certain subjects from a study based
on volume measurements, we are accepting that physical brain abnormalities do
inherently result in psychological abnormalities.
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4.2 Neuropsychology
Neuropsychologists are involved in diagnosis, patient care and planning of treatment,
and rehabilitation and treatment evaluation.
Diagnosis: Neuropsychology distinguishes between psychiatric and neurological
symptoms; neuropsychologists can find neurological disorders with no psychiatric
presentations, distinguish something as being a purely psychiatric manifestation with
no neurological deficit or vice versa, or localize the sight of a neurological deficiency
using behavioral data. Though advances in in vivo techniques (MRI, CT) may help
with diagnostics, neuropsychological techniques will still be necessary in diseases like
toxic encephalopathies because the quantitative equipment is not and will not be
sensitive enough.
The other arms of diagnosis are prediction and screening. Coma patients should
be assessed for prediction of outcomes using CT and MRI (van der Naalt (2001)).
This would allow for more accurate predictions in outome expectations. Blacker
et al. (2007) found that screenings could predict future cognitive decline.
Patient care and planning of treatment: A neuropsychologist is often used in
assessing patients after a medical event which can affect their cognition. The mental
requirements of a 55 year old stroke patient who is the CEO of a company differ
from those of a 27 year old construction worker involved in a vehicular accident. It
may be true that the CEO has to percept more than the construction worker, but if
the construction worker slips or drops equipment, an immediate danger is imposed
on the lives of others. The expectations of a patient affects the determination made
by the neuropsychologist.
Rehabilitation and treatment evaluation: A neuropsychologist may only give rec-
ommendations on what needs improvement based on tests (MRI, CT, or other paper
based exams), but will not administer the tests. For treatment evaluation, multiple
tests over a period of time would be formed and evaluated. In rare cases, a baseline
assessment might have been performed before the brain assault occured (perhaps in
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Figure 4.1: A concept of how technology matures
a screening).
Research: Research into new testing methods and combining other testing meth-
ods is a part of the neuropsychological field. Research allows for the validation of
old methods and the impetus to explore new ones. In 1983, MRI machines became
more prevalent in clinical medicine (Mattson and Simon (1996)). With the advent
of a new assessment technology came the need to validate the technology from the
neuropsychological perspective. Once MRI had been validated from the viewpoint of
neurologists, it was time to begin validating neurological exams from the perspective
of MRI. Once new technologies such as functional MRI are now in the process of
validating other theories.
The use of quality control charts will hopefully follow a similar pattern. The tech-
nology will be added to the structural measurements to assess morphometrics. When
the control charts have been validated as a method of assessment, then they can be
used in screenings by neuropsychologists. It would be useful if a neuropsychologist
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could accurately inform a patient that based on previous MRI measures, they can
expect a certain physiological outcome. The neuropsychologist may be capable of
discussing preventive measures as well.
4.3 Neuropsychology and Modeling
A neuropsychologist attempts to incorporate all the known data into a tapestry which
will give potential future outcomes and eliminate unlikely scenarios. They build a
model based on prior models that they have developed or researched. They have
before them the predictor variables, behavioral data from psychological tests and
MRI/CT scans, and are asked to determine future outcomes or proper treatment.
The patient’s condition is not static. As the neuropsychologist gets to know the pa-
tient better, the neuropsychologist gets a picture of the patient’s variability. Adding
quantitatively valid scans to the repertoire of tools could help the neuropsychologist
assess potential outcomes earlier. A quantitatively valid scan is similar to the other
tools diagnosticians in other fields use to assess a patient’s health. When a patient
sees a family practice doctor for high cholesterol, the doctor knows that the patient
is at risk for coronary artery disease, stroke, or blood clots. Diagnosticians have even
started to classify the risks associated with different cholesterol levels. Quantitive
scanning attempts to allow the neuropsychologist the same insight into a patient’s
future risk. Quantitative scanning over time on a patient should also allow a neu-
ropsychologist to chart disease progression. If an older patient arrives with enlarged
ventricles and those ventricles slowly increase over time, quantitative assessments
will detect the increase. The brain’s morphology is not static. This is another rea-
son why control charts are good for patient care. The control chart allows for the
quantitative variability to be assessed as being normal over time or out of control.
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Chapter 5
Study Design and Implementation
The study was developed at the MIND Institute at the University of New Mexico.
The principal investigator, Dr. Rex Jung (PI), is a trained psychologist. The primary
goal of the study was to investigate the contribution of white matter integrity to
broad measures of cognition and personality in normal subjects, but this thesis is
using only the sMR data. All scans were done on a 1.5 Tesla scanner at the Mind
Research Network. All imaging sequences used standard imaging parameters, well
established in clinical and research settings. This study was University of New Mexico
Institutional Review Board approved and met all necessary standards for human
protections. One protection is radiological review, results of which are compared
against the control charts.
• Subjects and Screening:
Subjects were recruited from the UNM campus via informational postings.
Only subjects in the age range of 18-25 were considered in order to minimize
age effects on brain development. To ensure that the subjects were in good
physical and mental health, an interview and physical history was conducted by
a licensed psychologist. Exclusion criteria included: 1) pregnancy, 2) presence
of a potentially dangerous metallic device, implanted or otherwise, 3) age less
than 18 or greater than 25, 4) presence of a medical, neurological, or psychi-
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atric condition that makes MRI scanning dangerous or confounds experimental
hypotheses. 71 subjects were collected.
• Procedure:
The study took place at the MIND Institute over one experimental session
consisting of five hours in total. The Principal Investigator (PI), (REJ), con-
ducted all the screening and interview procedures. The PI or his assistants
conducted MRI scanning and administration of cognitive and personality mea-
sures. The experimental session consisted of consent and screening (.75 hours),
MRI studies including morphological, diffusion tensor, and spectroscopic imag-
ing (allowed for 2 hours) and cognitive/personality/creativity evaluation (2.25
hours) for a total of 5 hours. Participants were paid $50 for their time.
• Magnetic Resonance Imaging (MRI) Studies:
MRI examinations were performed on a 1.5 Tesla Siemens Sonata scanner us-
ing an 8-channel phased array head coil. T1-weighted images were obtained
with a 3D transversal gradient echo sequence (TR/TE=12/4.76ms, field of
view (FOV) = 200x200mm, flip angle 200, resolution 192x192, slice thick-
ness=1.5mm, structural scan time = 6 minutes 47 seconds). The scan time was
1.25 hours, but up to two hours were available if needed. FreeSurfer software
was used to segment brain regions into regional brain volumes (i.e., cortical
thickness x gyral area) (Fischl and Dale (2000) and Fischl et al. (2004)).
5.1 Implementing Control Charts for QA
Whole volume and normalized volume control limits are calculated by averaging all
regional segmented volumes across subjects and finding the standard deviation. The
Upper Control Limit and Lower Control Limit were calculated from the data by
looking at 3 standard deviations from the sample mean. Since this is considered
Phase I, the use of these control limits in Phase II would be changed by deleting
outliers, and recalculating the mean and standard deviation. Many structures do
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not follow a normal distribution, but Montgomery (2005) notes that for univariate
control charts this assumption is not necessary.
For these data, we take the individual brain structure volumes along with the
hemispherically summed and differenced volumes and divide them by the intracra-
nial volume. This deflects egregious site, gender, volume, and age differences (Tofts
(2003)). Standardized control charts should not be used on the normalized data be-
cause the normalization makes the brains (or segmentations) very similar. The data
was normalized to make each brain as similar as possible which means standardizing
the original data is not useful.
5.2 Overview of Charts
Subject 19 appears in all three quality control charts: Whole Volume Charts, Nor-
malized charts, and Regression control charts and therefore can be used to illustrate
each chart’s features and interrelationships. Subject 19 is a 19-year-old right-handed
female with an IQ of 116. Subjects were recruited mainly from the UNM campus
which means that our sample is not a good representation of the general population
of healthy 18-25 year olds. After contacting the researcher or his assistant, she was
given a psychological review and interview. She then was given the MRI scan. A
radiologist reviewed her scan to look for abnormalities. The data was later processed
using the Freesurfer software, the measurements aggregated, and SAS was used to
create quality control charts.
Whole volume charts flagged her as outside the upper bounds for Right Cerebel-
lum White Matter and Summed Cerebellum White Matter. The Right Cerebellum
White Matter is obviously large enough to place the summed structure out of con-
trol. She was not flagged as being quantitatively asymmetrical for this structure.
Her normalized Right Cerebellum White Matter was also found to be out of control.
IQ was found to be the only significant regressor for the Right and Summed Cerebel-
lum White Matter. Gender, age, and handedness were not significant regressors and
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were back selected out from the model. Note that each of the different methodologies
flagged the same structure.
Whole Volume Charts
One example “whole volume control chart” is given in Figure 5.1. The volumes
are measured in cubic millimeters. Charts for all volumes were created using the
SAS macro programming language.
Figure 5.1: A whole volume control chart indicating two subject’s ventricles are larger
than expected. Enlarged ventricles are implicated in schizophrenia, Alzheimer’s,
alcoholism, and other mental disorders. Not all 71 subjects are shown, but the rest
of the subjects were in control.
Whole volume charts are hindered because the tools being used to measure a
product, that is not itself homogenous, have their own variability. Steen et al. (2007)
also looked at healthy normal controls, but his subject’s brain volumes were larger.
A comparison of studies will show the fact that site has an affect on the volumet-
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rics. Using Steen et al. (2007) to establish our control limits would render a good
proportion of our subjects as being out of control. The Freesurfer volumes that are
readily available for comparison came from multiple sites. We used our data for the
control charts limits to avoid adding the variability across sites to charts. Biological
differences, such as age or gender, affect brain volumes (Tofts (2003)). Because of
the multitude of factors affecting brain volumetrics, several control limits may need
to be established for different populations.
Table 5.1 is a summary from the whole volume control charts of the subjects’
structures found to be outside of control limits. ID is the subject’s unique identi-
fier. Volume refers to the cubic millimeters of the structure, and Structure (Whole
Volume) refers to which structure was found to be out of control. Structures with
“Differenced” in the name occur when the left hemisphere has been subtracted from
the right hemisphere. “Summed” means the hemispheres were summed. Differenc-
ing was performed to look for asymmetries across hemispheres which the radiologist
is able to do qualitatively and summing was performed to see if the hemispheres
balanced each other out. Most subjects found out of control break the upper control
limit (a result that will be further explored with a larger data set). Again SAS Macros
were used to generate this table and only subjects’ structural volumes outside of the
control limits are presented. This summary allows for the reader to see the number
of subjects and structures that were tested and found to be outside normal limits.
Notice that there are repeat outliers in subject 34. Our subjects were expected to
be healthy normal controls, but (Vernooij et al. (2007); Katzman et al. (1999) also
reported incidental findings in asymptomatic volunteers.
Percent Volumes
The subject flagged in the percent volume chart (Figure 5.2) was not flagged in
the whole volume chart.
Subject 31 was considered healthy by the psychological reviews. Notice the sub-
ject is barely outside the control limits, but physiological data (i.e. regional brain
volume measures) has a great amount of variability (Tofts (2003)).
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Figure 5.2: Control chart based on the percentage of total brain volume the brain
structure occupies. These control charts are better suited for multiple site/scanner
acquisitions.
Table 5.2 gives a summary of the structures found to be out of control for nor-
malized volumes. ID refers to the subject’s unique identifier. Volume refers to the
percentage of the volume that the structure occupies relative to whole brain volume.
Structure (Normalized Volume) refers to the structure that was outside of normal
limits. “Differenced” and “Summed” have the same meaning as above, except for
the normalization factor. SAS Macros were used to generate the table. Notice that
more outliers were detected across more subjects and that percent volume charts
are more sensitive. A type I error may occur here, i.e. flagging someone as out of
control when they are not. Type I errors in health data are preferable to Type II
errors because follow up will be performed if someone is considered outside normal
limits. Note the number of repeat outliers (19, 20, and 34) within subjects and that
subject 34 disappears as an outlier in the percent volume charts (Table 5.2). Subject
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ID Structure (Whole Volume) Volume (mm3)
2 Right Putamen 3987
8 Fourth Ventricle 4094
10 Third Ventricle 1556
15 Right Amygdala 2236
19
Right Cerebellum White Matter 20299
Summed Cerebellum White Matter 44108
20
Left Lateral Ventricle 18670
Third Ventricle 1798
22 Differenced Caudate -701
31 Right Inferior Lateral Ventricle 1164
33 Summed Accumbens area 1683
34
Left Cerebral Cortex 377543
Right Caudate 5597
Right Cerebral Cortex 369986
Summed Cerebral Cortex 747529
Fourth Ventricle 4020
35 Differenced Cerebellum Cortex -5439
52 Left Inferior Lateral Ventricle 1264
56 Right Cerebellum White Matter 19138
65 Left Lateral Ventricle 16808
68 Differenced Putamen -953
Table 5.1: Outliers from control charts using original brain volume measures
34 does not have the largest intracranial volume measures of the study which makes
the disappearance of the flag surprising.
Regression Control Charts
Hawkins (2003) and Mandel (1969) guided the use of regression control charts.
It was intended that a multivariate control chart be used, and (Mason et al. (1995)
suggested a method for decomposing Hotelling’s T 2 statistic so that the actual cause
of an out of control flag could be determined, but multivariate control charts did
not prove to be an appropriate method for including behavioral data. Therefore, a
regression control chart was more appropriate and simpler both in use and imple-
mentation.
The advantages to usng regressions are: (1) The number of variables included in
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the regression model is limited only by the number of variables that are collected,
but selection methods exist for decreasing the number of variables; (2) behavioral as
well as other structural data can be incorporated into the model; (3) the residuals
are a standardization of the dependent variable. The regressions highlight corre-
lations between structures, and with behavioral data included, this can highlight
well-correlated structures involved in disease processes and suggest new avenues of
research.
Regression control charts (Mandel (1969)) are the next step to “normalize” a
brain across subejcts since normalization by the intracranial volume does not handle
gender differences. Nor is it likely to account for mental illness. Regression control
charts can be very powerful and much more sensitive because they use the residuals
as the plotting point rather than the original measure. Instead of accounting for
intracranial volume, regression control charts can account for IQ, spatially-related
structures, and psychiatric diagnosis. Unfortunately a researcher might be tempted
to over-parameterize the control chart.
In order to prevent over-parameterization, the initial regressors were picked be-
cause of structural relationships, i.e. one structure in the left hemisphere was re-
gressed by the other remaining left hemisphere structures. We did not use across
hemisphere regressors due to the fact that structures across hemispheres were highly
correlated and we would have issues with collinearity. We used PROC REG in SAS
with selection “backward” to select variables.
The structural regressions performed were: Left against left, right against right,
normalized left against normalized left, normalized right against normalized right.
Since this study had demographic data, we also did regressions on age, gender,
dominant hand use, and IQ. Since IQ is such a polarizing statistic, we also regressed
with only IQ.
Women have smaller brain volumes than men, which would justify using in-
tracranial normalization to account for gender effects, but the distribution of grey
and white matter is also different between genders (Tofts (2003)). Women have
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smaller white matter volumes and men have larger grey matter volumes Tofts (2003)
which complicates the usefulness of intracranial normalization. Regression on many
of the structures confirms that gender remains a significant regressor for normal-
ized volumes in some regions. These structures were the right and left hemispheres
of the thalamus, putamen, pallidum, hippocampus, cerebral white matter, cerebral
cortex, cerebellum white matter, cerebellum cortex, and caudate. Gender was also
significant when right and left hemispheres had been differenced which means that
brain asymmetries are correlated with gender. The purpose of this study was control
charts and so exploring gender as it relates to morphology was best left to other
researchers, but these data suggested that gender may be more deterministic of the
composition of brain morphology. Women and men not only have differences in the
size of their brains, but also in the integration of structures. Perhaps rather than
comparing raw measures from MR modalities or even normalized measures, studies
might need to focus on comparing residuals after controlling for gender (or age).
Tables 5.3 and 5.4 represent the outliers found using regression control charts.
As can be expected, many structures are listed as out of control multiple times.
Subject 55 has a right accumbens that is flagged as out of control after regression
on the structures in the right hemisphere, after normalization and regression on
IQ, after normalization and regression on structures in the right hemisphere, after
normalization and regression on Age, Gender, and IQ. This structure is obviously
out of control and the multiple flags only support that. More structures are flagged
with regression control charts, but some structures can be flagged multiple times.
The radiologist and psychologist flagged the subjects listed below, but for reasons
our control charts were not able to detect. The Freesurfer software does not find cysts
or demyelinating disease.1 Myelin allows for faster transfer of information across
axons; demyelination is a deficiency of myelin that causes the axonal connections
to “short-circuit.” The radiologist flagged someone for being asymmetrical, but this
is a qualitative assessment. Our control charts can quantitatively look for volume
1There is software being developed through the National Alliance for Medical Image
Computing (www.na-mic.org) project to automatically detect demyelination.
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Figure 5.3: Regression control chart using other right hemisphere structures as pre-
dictors. The pallidum and cerebellum cortex were significant regressors after back-
wards selection.
asymmetry.
It is surprising to see that the Summed Accumbens Area for subject 33 in Table
5.1 is outside normal limits while the two separate hemispheres are not outside of
normal limits. Such anomalies lead us to think multivariate control charts will need
to be explored as well as other summations and differences. The radiologist’s findings
also hint at other research projects. If software could parcellate cysts from normal
brain matter, the computer could make the measurement performed on subject 5 and
inform the doctor of their presence in subject 55. Demyelinating disease is currently
being studied in other projects. Asymmetries can also be assessed if that particular
structure was measured. Quantitative scans and the software that parcellates the
results can add numeric credence to the radiologists professional judgment.
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5.3 The Costs of Scanning
The cost of an MRI scan at the Mind Research Network is ≈$650/hr. This study
required 1.25 hours of scan time, but studies involving functional MRI can be longer
(2-3 hours). Poor structural images that cannot be processed can ruin a region of
interest analysis. Quality control of the structural images would help to mitigate this
loss of data because it is much easier to repeat a 7 minute structural scan while a
subject is already in the scanner than it is to get a subject to return, especially if they
have traveled for the scan. Moderately-sized studies often have 50-100 subjects which
translates to 50-300 hours of scan time or ≈$32,500-$195,000. A low 1% attrition
rate would mean as little as ≈$325-$1,950 in lost scan time. Most studies we have
been associated with lose more than 1% of their data due to bad scans. There are
costs associated with recruitment and analysis which are not factored in. Those costs
increase significantly for harder to find populations such as lupus patients (personal
experience with other projects). From a cost perspective, performing automated QA
on scans is prudent.
5.4 Conclusions and Future Work
Control Charts are not a substitute for radiological review, but can quantify the
radiologists findings. They are intended to assure that the subject is in the same
range expected for their health status and thereby keep study populations as close
to expectations as possible. They can give automated feedback about a patient, and
alert the technicians to bad scans sooner than a one week review would. If a patient
is outside of normal limits, they can signal a need for a re-evaluation. In the future,
control charts may aid in rapid detection of brain abnormalities, bad scan runs, and
flag subjects who may be outliers in study cohorts. Control charts can help in the
assessment of drugs being developed, especially when a series of images are taken
over a period of time (cf Tofts (2003)). As an example, a brain infarct causes a
loss of blood flow to a region and thereby increases atrophy in that region. A drug
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that increases blood flow within the brain can be statistically assessed, based on
morphological measures taken over several weeks, to see if the drug actually reduces
atrophy and the rate of deterioration.
Future imaging technology will likely be faster and increase both in sensitivity
and specificity allowing for cheaper scans that have greater resolution. While this
would make them a valuable routine diagnostic tool, as the resolution increases, the
amount of time a radiologist spends on each scan (as well as cost) will increase.
Using automated procedures can assist in flagging outliers and inconsistencies that
might occur and be of great benefit in other imaging modalities. With greater
scan resolution, the human eye will not be able to capture every detail and a down
sampling of the data will be a likely work around. Software and computers do not
require down sampling. Both technologies can be used to parse out brain structures,
look for tumors or lesions, and with repeated scans, the technologies can begin to
discern changes in pathology.
Neuropsychologists look at covariates along with images which suggests a regres-
sion control chart. Regressing the volume measures by the behavioral data allows
the neuropsychologist to standardize the volume measures across patient type and
demographics. Using the resulting residuals would allow for one set of control limits
to be used across several differing populations. A neuropsychologist would then have
another quantitative measure to compliment the patient assessments.
In the future, we would like to explore multivariate control charts because many
disease processes affect more than one region. Difficulties lie in transforming the data
and checking for normality, relation of structures in disease, and which multivariate
control chart(s) should be implemented for most efficient detection. Decomposition
of Hotelling’s T 2 statistic can facilitate detecting which structures are contributing
most to an out of control flag (Mason et al. (1995)).
Other imaging modalities were involved in this study, and we plan on developing
quality control charts for the Diffusion Tensor imaging data. Multivariate control
charts and regression control charts can be used on these other modalities as well.
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The different image modalities can be used as parameters to the multivariate control
chart.
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ID Structure (Normalized Volume) Percent of Total
Brain Volume
8 Fourth Ventricle 0.00267
10 Third Ventricle 0.00092
17
Left Cerebellum Cortex 0.04572
Right Cerebellum Cortex 0.04661
Summed Cerebellum Cortex 0.09233
18 Fourth Ventricle 0.00265
19 Right Cerebellum White Matter 0.01146
20 Third Ventricle 0.00094
22 Differenced Caudate -0.00046
31
Left Thalamus Proper 0.00615
Right Inferior Lateral Ventricle 0.00083
Summed Inferior Lateral Ventricle 0.00136
Summed Thalamus Proper 0.01164
32 Right Thalamus Proper 0.00578
35 Differenced Cerebellum Cortex -0.00303
51
Differenced Cerebellum Cortex 0.00450
Differenced Cerebral Cortex 0.01217
52
Left Cerebral White Matter 0.13609
Left Inferior Lateral Ventricle 0.00075
53
Left Amygdala 0.00150
Right Amygdala 0.00144
Summed Amygdala 0.00295
55 Right Accumbens area 0.00056
56
Right Cerebellum White Matter 0.01283
Summed Cerebellum White Matter 0.02683
65 Left Lateral Ventricle 0.00987
68 Differenced Putamen -0.00056
Table 5.2: Control charts using normalized brain volumes.
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ID Structure
12
Regressed IQ on Left Accumbens area
Regressed Behavioral Data on Left Accumbens area
Regressed Behavioral Data on Differenced Accumbens area
13
Right Structures Regressed on Right Caudate
Regressed Behavioral Data on Right Caudate
Regressed Behavioral Data on Summed Caudate
16 Regressed Behavioral Data on Differenced Inferior Lateral Ventricle
17
Left Structures Regressed on Left Cerebellum Cortex
Right Structures Regressed on Right Cerebellum Cortex
19
Regressed IQ on Right Cerebellum White Matter
Regressed IQ on Summed Cerebellum White Matter
Regressed Behavioral Data on Right Cerebellum White Matter
Regressed Behavioral Data on Summed Cerebellum White Matter
20
Regressed IQ on Left Lateral Ventricle
Regressed Behavioral Data on Left Lateral Ventricle
22
Regressed IQ on Differenced Caudate
Regressed Behavioral Data on Differenced Caudate
26
Regressed IQ on Left Thalamus Proper
Regressed IQ on Summed Pallidum
Regressed IQ on Summed Thalamus Proper
Regressed Behavioral Data on Left Pallidum
Regressed Behavioral Data on Left Thalamus Proper
Regressed Behavioral Data on Right Pallidum
Regressed Behavioral Data on Right Thalamus Proper
Regressed Behavioral Data on Summed Pallidum
Regressed Behavioral Data on Summed Thalamus Proper
31
Right Structures Regressed on Right Inferior Lateral Ventricle
Regressed IQ on Right Inferior Lateral Ventricle
Regressed IQ on Left Thalamus Proper
Regressed IQ on Right Inferior Lateral Ventricle
Regressed IQ on Summed Inferior Lateral Ventricle
Regressed Behavioral Data on Right Inferior Lateral Ventricle
Regressed Behavioral Data on Summed Inferior Lateral Ventricle
Table 5.3: Outliers from control charts using residuals from regression
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ID Structure
32 Right Structures Regressed on Right Thalamus Proper
35
Regressed IQ on Differenced Cerebellum Cortex
Regressed Behavioral Data on Differenced Cerebellum Cortex
36
Regressed IQ on Left Putamen
Regressed IQ on Right Putamen
Regressed IQ on Summed Putamen
Regressed Behavioral Data on Left Putamen
Regressed Behavioral Data on Right Putamen
Regressed Behavioral Data on Summed Putamen
38
Regressed Behavioral Data on Left Pallidum
Regressed Behavioral Data on Summed Pallidum
52 Regressed IQ on Left Inferior Lateral Ventricle
53
Regressed IQ on Left Amygdala
Regressed IQ on Summed Amygdala
Regressed Behavioral Data on Left Accumbens area
Regressed Behavioral Data on Left Amygdala
54 Right Structures Regressed on Right Lateral Ventricle
55
Right Structures Regressed on Right Accumbens area
Regressed IQ on Right Accumbens area
Regressed Behavioral Data on Right Accumbens area
56 Right Structures Regressed on Right Cerebellum White Matter
63 Left Structures Regressed on Left Cerebral Cortex
65 Regressed IQ on Left Lateral Ventricle
68
Regressed IQ on Differenced Putamen
Regressed Behavioral Data on Differenced Putamen
Table 5.4: Outliers from control charts using residuals from regression, continued
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Table 5.5: Findings by the radiologist
ID RECOMMENDATION Keep in Study
5 Benign finding. Cyst of the par
intermedia measuring 4mm.
YES
42 Ventricular asymmetry, normal
variant. No action needed.
YES
44 Findings consistent with demyeli-
nating disease; MS.
NO
55 Small bilateral mucous retention
cysts in the maxillary sinuses are
of little clinical significance. No
specific action required.
YES
61 None. Moderate to severe chronic
paranasal sinus disease.
YES
64 Asymmetry of the temporal horns
with the right larger than the left.
May be normal anatomic variant.
If subject has history of seizure,
this may be an early finding of
mesial temporal sclerosis.
NO
67 Correlate to subject history NO
51
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